2005 Annual Meeting | Contemporary Clinical Issues and Case Studies Plenary Session
| 09:00 AM - 09:05 AM |
Introduction to CCI Plenary Session
John H. Noseworthy, MD, FAAN |
|
| 09:00 AM - 12:00 PM |
Break
|
|
| 09:05 AM - 09:20 AM |
Presentation of AAN Lifetime Achievement Award
|
|
| 09:20 AM - 09:30 AM |
Establishing Subtypes of the Continuum of Frontal Lobe Impairment in ALS
Catherine Lomen-Hoerth, MD, PhD, FAAN |
|
| 09:30 AM - 09:40 AM |
Discussant
Hiroshi Mitsumoto, MD, FAAN |
|
| 09:40 AM - 09:50 AM |
A Double Blind, Multicenter Trial Comparing Duloxetine with Placebo in the Treatment of Diabetic Peripheral Neuropathic Pain
Joachim F. Wernicke, MD, PhD |
|
| 09:50 AM - 10:00 AM |
Discussant
Michael J. Polydefkis, MD, FAAN |
|
| 10:00 AM - 10:10 AM |
Cognitive Effects of Donepezil and Vitamin E in Mild Cognitive Impairment
Leon J. Thal, MD |
|
| 10:10 AM - 10:20 AM |
Discussant
David S. Knopman, MD, FAAN |
|
| 10:20 AM - 10:40 AM |
The Genetics of Parkinson's Disease
Christine Klein, MD |
|
| 10:40 AM - 11:00 AM |
The Treatment of Glioblastoma Multiforme (GBM)
John W. Henson, MD, FAAN |
|
| 11:00 AM - 11:20 AM |
The Spectrum of Recently FDA Approved Devices for the Management of Stroke Disorders
Kyra J. Becker, MD |
| John W. Henson, MD, FAAN | No disclosure on file |
| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Kyra J. Becker, MD | No disclosure on file |
| Christine Klein, MD | Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care. |
| Hiroshi Mitsumoto, MD, FAAN | Dr. Mitsumoto has nothing to disclose. |
| John H. Noseworthy, MD, FAAN | No disclosure on file |
| Catherine Lomen-Hoerth, MD, PhD, FAAN | Dr. Lomen-Hoerth has nothing to disclose. |
| Joachim F. Wernicke, MD, PhD | No disclosure on file |
| Michael J. Polydefkis, MD, FAAN | Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. |
| Leon J. Thal, MD | No disclosure on file |
| No disclosure on file |